Fluoroquinolone-induced suicidal ideation

General Hospital Psychiatry

Volumn 32, Issue 1, 2010, Pages 108-110

  LaSalvia, Elizabeth A ^a   Domek, Gretchen J ^b   Gitlin, David F ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Brigham and Women's/Faulkner Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; LEVOFLOXACIN; METRONIDAZOLE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ANHEDONIA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; COLORECTAL CANCER; CONCENTRATION LOSS; CREATININE BLOOD LEVEL; DEHYDRATION; DEPRESSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS; ESCHERICHIA COLI; HOPELESSNESS; HOSPITAL READMISSION; HUMAN; MALE; NAUSEA; POTASSIUM BLOOD LEVEL; PSYCHOMOTOR RETARDATION; SUICIDAL IDEATION; UREA NITROGEN BLOOD LEVEL; VOMITING; WOUND DRAINAGE; WOUND INFECTION;

AGED; ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM; FLUOROQUINOLONES; HUMANS; MALE; SUICIDE;

EID: 73749084219     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2009.03.002     Document Type: Article

References (37)

1. Croom K.F., and Goa K.L. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs 63 (2003) 2769-2802
2. Leone R., Venegoni M., Motola D., Moretti U., Piazzetta V., Cocci A., et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials. Drug Safety 26 (2003) 109-120
3. Carbon C. Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 47 Suppl 3 (2001) 9-14
4. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 26 Suppl. B (1990) 219-225
5. Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 127 (2002) 269-277
6. Ortho-McNeil Pharmaceutical, Inc. Levaquin Product Insert.
7. James E.A., and Demian A.Z. Acute psychosis in a trauma patient due to ciprofloxacin. Postgrad Med J 74 (1998) 189-190
8. McCue J.D., and Zandt J.R. Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole. Am J Med 90 (1991) 528-529
9. Mulhall J.P., and Bergmann L.S. Ciprofloxacin-induced acute psychosis. Urology 46 (1995) 102-103
10. Zaudig M., Von Bose M., Weber M., Bremer D., and Zieglgansberger W. Psychotoxic effects of ofloxacin. Pharmacopsychiatry 22 (1989) 11-15
11. Akhtar S., and Ahmad H. Ciprofloxacin-induced catatonia. J Clin Psychiatry 54 (1993) 115-116
12. Kushner J., Peckman H.J., and Snyder C.R. Seizures associated with fluoroquinolones. Ann Pharmacother 35 (2001) 1194-1197
13. Farrington J., Stoudemire A., and Tierney J. The role of ciprofloxacin in a patient with delirium due to multiple etiologies. Gen Hosp Psychiatry 17 (1995) 47-53
14. Ball P., and Tillotson G. Tolerability of fluoroquinolone antibiotics past, present, and future. Drug Safety 13 (1995) 343-358
15. Lode H. Potential interactions of the extended-spectrum fluoroquinolones with the CNS. Drug Safety 21 (1999) 123-135
16. Domagala J.M. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 33 (1994) 685-706
17. Mehlhorn A.J., and Brown D.A. Safety concerns with fluoroquinolones. Ann Pharmacother 41 (2007) 1859-1866
18. Owens R.C., and Ambrose P.G. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41 Suppl 2 (2005) S144-S157
19. Unseld E., Ziegler G., Gemeinhardt A., Janssen U., and Klotz U. Possible interaction of fluoroquinolones with the benzodiazepine-GABA-receptor complex. Br J Clin Pharmacol 30 (1990) 63-70
20. Sanacora G., and Saricicek A. GABAergic Contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 6 (2007) 127-140
21. Christ W., Gindler K., Gruene S., Hecker W., Jacobsen M., Junge H., et al. Interactions of quinolones with opioid and fenbufen, a nonsteroidal anti-inflammatory drug: involvement of dopaminergic neurotransmission. Rev Infect Dis 11 suppl 5 (1989) S1393-S1394
22. Feinberg S.S. Fluoroquinolone-induced depression. Am J Psychiatry 152 (1995) 954-955
23. Stahlmann R., and Lode H. Fluoroquinolones in the elderly. Drugs Aging 20 (2003) 289-302
24. Pittenger C., Sanacora G., and Krystal J.H. The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disord Drug Targets 6 (2007) 101-115
25. Pilc A., Chaki S., Nowak G., and Witkin J.M. Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 75 (2008) 997-1006
26. Witkin J.M., Marek G.J., Johnson B.G., and Schoepp D.D. Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets 6 (2007) 87-100
27. Hall C.E., Keegan H., and Rogstad K.E. Psychiatric side effects of ofloxacin used in the treatment of pelvic inflammatory disease. Int J STD AIDS 14 (2003) 636-637
28. Jick S.S., Vasilakis C., Martinez C., and Jick H. A study if the relation of exposure to quinolones and suicidal behavior. Br J Clin Pharmacol 45 (1998) 77-81
29. Patten S.B. Non-psychiatric therapeutic medications in the etiology of organic depression. Psychiatr J Univ Ott 15 (1990) 150-155
30. Patten S.B., and Love E.J. Drug-induced depression incidence, avoidance, and management. Drug Safety 10 (1994) 203-219
31. Patten S.B., and Love E.J. Drug-induced depression. Psychother Psychosom 66 (1997) 63-73
32. Patten S.B., and Lamarre C.J. Can drug-induced depressions be identified by their clinical features?. Can J Psychiatry 37 (1992) 213-215
33. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
34. Grassi L., Biancosino B., Pavanti M., Agostini M., and Manfredini R. Depression or hypoactive delirium? A report of ciprofloxacin-induced mental disorder in a patient with chronic obstructive pulmonary disease. Psychother Psychopharm 70 (2001) 58-59
35. Wambulwa C., Bwayo S., Laiyemo A.O., and Lombardo F. Trimethoprim-sulfamethoxazole-induced aseptic meningitis. J Natl Med Assoc 97 (2005) 1725-1728
36. Saidinejad M., Ewald M.B., and Shannon M.W. Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration. Pediatrics 115 (2005) e739-e741
37. Saxe T.G. Severe depression from TMP-SMX. Drug Intell Clin Pharm 22 (1998) 267